Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term chemotherapy. Found 241 abstracts

no pagination
Lattanzi JP, Coia LR, Scher RM, Engstrom PF, Hoffman JP, Eisenberg BF, Sigursdson ER, Epstein BE, Weiner LM. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver. Gi Cancer. 1997 Jan;2(2):111-7.
Ozols RF. Controversies in the management of ovarian cancer. International Journal of Gynecological Cancer. 1997 May;7:27-32.
Ozols RF. Gynecologic oncology group trials in ovarian carcinoma. Seminars in Oncology. 1997 Feb;24(1):S10-S12.
Street JC, Szwergold BS, Matei C, Kappler F, Mahmood U, Brown TR, Koutcher JA. Study of the metabolism of choline and phosphatidylcholine in tumors in vivo using phosphonium-choline. Magnetic Resonance in Medicine. 1997 Nov;38(5):769-75.
Allen SL, Schacter LP, Lichtman SM, Bukowski R, Fusco D, Hensley M, Odwyer P, Mittelman A, Rosenbloom B, Huybensz S. Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma. Investigational New Drugs. 1996 Jan;14(2):213-7.
Cryer JE, Johnson SW, Engelsberg BN, Billings PC. Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin. Cancer Chemotherapy and Pharmacology. 1996 Jun;38(2):163-8.
Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER, Daly MB, Goldstein LJ. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. International Journal of Radiation Oncology Biology Physics. 1996 Jul;35(4):669-77.
Gordon LI, Andersen J, Habermann TM, Winter JN, Glick J, Schilder RJ, Cassileth P. Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: Determination of the Maximum-tolerated dose of ProMACE-CytaBOM. Journal of Clinical Oncology. 1996 Apr;14(4):1275-81.
Hoffman JP, Odwyer P, Agarwal P, Salazar H, Ahmad N. Preoperative chemoradiotherapy for localized pancreatic carcinoma - A perspective. Cancer. 1996 Aug;78(3):592-7.
Li CW, Negendank WG, PadavicShaller KA, Odwyer PJ, MurphyBoesch J, Brown TR. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized F-19 magnetic resonance spectroscopy. Clinical Cancer Research. 1996 Feb;2(2):339-45.
Tester W, Caplan R, Heaney J, Venner P, Whittington R, Byhardt R, True L, Shipley W. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: Results of Radiation Therapy Oncology Group phase II trial 8802. Journal of Clinical Oncology. 1996 Jan;14(1):119-26.
Algan O, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE. Management of Adenocarcinoma of the Esophagus with Chemoradiation Alone or Chemoradiation Followed by Esophagectomy - Results of Sequential Nonrandomized Phase-Ii Studies. International Journal of Radiation Oncology Biology Physics. 1995 Jun 15;32(3):753-61.
Corn BW, Greven KM, Randall ME, Wolfson AH, Kim RY, Lanciano RM. The Efficacy of Cranial Irradiation in Ovarian-Cancer Metastatic to the Brain - Analysis of 32 Cases. Obstetrics and gynecology. 1995 Dec;86(6):955-9.
Crilley P, Goldstein LJ. Peripheral-Blood Stem-Cell Transplant in Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):238-49.
Devineni D, Kleinszanto A, Gallo JM. Tissue Distribution of Methotrexate Following Administration as a Solution and as a Magnetic Microsphere Conjugate in Rats Bearing Brain-Tumors. Journal of Neuro-Oncology. 1995 Jan;24(2):143-52.
Fein DA, Lee WR, Lanciano RM, Corn BW, Herbert SH, Hanlon AL, Hoffman JP, Eisenberg BL, Coia LR. Management of Extremity Soft-Tissue Sarcomas with Limb-Sparing Surgery and Postoperative Irradiation - Do Total-Dose, Overall Treatment Time, and the Surgery-Radiotherapy Interval Impact on Local-Control. International Journal of Radiation Oncology Biology Physics. 1995 Jul 15;32(4):969-76.
Kruh GD, Gaughan KT, Godwin A, Chan A. Expression Pattern of Mrp in Human Tissues and Adult Solid Tumor-Cell Lines. Journal of the National Cancer Institute. 1995 Aug 16;87(16):1256-8.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF. Paclitaxel by 24- or 1-Hour Infusion in Combination with Carboplatin in Advanced Nonsmall Cell Lung-Cancer - the Fox Chase Cancer Center Experience. Seminars in Oncology. 1995 Aug;22(4):18-29.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-Small-Cell Lung-Cancer - a Phase-Ii Toxicity, Response, and Survival Analysis. Journal of Clinical Oncology. 1995 Aug;13(8):1860-70.
Martenson JA, Lipsitz SR, Lefkopoulou M, Engstrom PF, Dayal YY, Cobau CD, Oken MM, Haller DG. Results of Combined-Modality Therapy for Patients with Anal Cancer (E7283) - an Eastern-Cooperative-Oncology-Group-Study. Cancer. 1995 Nov 15;76(10):1731-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term chemotherapy

chemotherapy cancer carcinoma therapy radiation-therapy irradiation cisplatin resistance doxorubicin randomized trial induction intensity survival cooperative-oncology-group radiotherapy taxol 5- radiation fluorouracil conservative surgery murine fibro-sarcoma squamous-cell carcinoma tamoxifen drug delivery adenocarcinoma of the esophagus colony- phase-ii combination breast-cancer term follow-up bir-4 extremity stimulating factor prognosis damaged dna multidrug transporter barrier clinical pharmacokinetics gene remission HMG proteins conservative surgery and radiation leukemia homology preoperative and esophagectomy progenitor cells pancreatic neoplasms hepatic carcinoma metabolism experience ovarian-cancer carboplatin adenocarcinoma creatinine clearance antitransferrin receptor antibody metastases extravascular transport whole abdomen irradiation pancreaticoduodenectomy adriamycin radiation therapy surgery p-31 nmr-spectroscopy prognostic factors site lymphoma cisplatin-cyclophosphamide fraction phase II survival rate support transhiatal esophagectomy lattice relaxation-times hydrolysis dosage salvage cystectomy antineoplastic transport adjuvant tamoxifen angle soft tissue sarcomas nuclear-magnetic-resonance sensitivity status CDDP-DNA phospholipids paclitaxel-cisplatin tumors region integration anus high-dose chemotherapy paclitaxel postoperative rt invivo brachytherapy serum creatinine radiation effects gynecologic-oncology-group limb sparing chemoradiation treatment regimens autologous bone-marrow breast motif tumor-cells lipid-metabolism cytoreductive surgery albumin microspheres randomized energy transitional-cell-carcinoma central-nervous-system tumor hypoxic cell vinblastine involvement new standard adjuvant cerebral metastases methotrexate nmr intra-arterial hepatocellular-carcinoma intraperitoneal chemotherapy management agents head trial standard regimen chop dose surgical resection non-hodgkins-lymphoma combination therapy plasma p-glycoprotein expression elsamitrucin disease-free survival adjuvant chemotherapy
Last updated on Thursday, June 04, 2020